Click Therapeutics, Inc.
Click Therapeutics is a digital therapeutics company that specializes in developing software as medical treatments for various health conditions, including depression and migraine. Their products are designed to be prescribed by healthcare professionals, targeting unmet medical needs through innovative digital solutions. The company operates within the healthcare technology sector, focusing on enhancing patient outcomes through evidence-based digital interventions.
Headcount
Website visitors
Workforce
Headcount by location
- United States100%
Split by department
- Engineering & R&D49%
- Healthcare7.9%
- Founder, Owner & Executive6.9%
- Legal & Compliance5.9%
- Other31%
Seniority distribution
- Less than 5 years51%
- 5 to 10 years35%
- 10 to 20 years8.1%
- 20 to 30 years3.0%
- 30 years and more3.0%
Funding
Raised to date
- 9 Apr 2026Series D$50.0MBoehringer Ingelheim
- 19 Mar 2025Undefined Funding$48.5MDassault Systèmes, Medidata Solutions
16 earlier rounds, with their terms and sources.
Investors
HsbcHSBC is a global bank and financial services firm headquartered in London. It offers personal, commercial and investment banking, wealth management and trade‑finance solutions to individuals, businesses and institutions worldwide, operating through1,723United Kingdom
H.I.G. CapitalH.I.G. Capital is a global investment manager that oversees roughly $75 billion in assets across private equity, growth equity, real‑estate, credit, infrastructure and special‑situations strategies. It provides capital and operational expertise to689United States
SanofiSanofi is a biopharmaceutical company focused on research and development of innovative medicines and vaccines. They serve healthcare providers, patients, and organizations by offering treatments for various diseases, including chronic and rare204France
Boehringer IngelheimBoehringer Ingelheim is a global, family‑owned pharmaceutical company that develops and manufactures human medicines, animal‑health products, and provides contract manufacturing for biopharmaceuticals. It serves patients, veterinarians and biotech82Germany
Portfolio
Countries
- Switzerland100%
Deal stage
- Asset Acquisition75%
- Series A25%
Deal size
- Unknown50%
- 50-20025%
- <125%
Company size
- 51-200100%
Revenue
EBITDA
Revenue source: Modeled estimate
Recent news
- Oura welcomes Sanjay Chandra as Chief Information Officer and Han Chiu as SVP of AI and Software Engineering.leaves
- Former Novo Nordisk North America chief joins board of US biotech company.hires
- Ross Muken to become CEO as SOPHiA GENETICS confirms succession plan ahead of Annual meeting.leaves
- Click Therapeutics cuts over a quarter of workforce.decreases headcount by
Portfolio companies
Every holding by name, with what was paid, when, and how each one has grown since
People
How the team has changed month by month — joiners, leavers and where the hiring is going
Connections
Who at your firm already knows someone here, and how warm the path is
The full Click Therapeutics, Inc. profile lives in Inven.
Your competitors are already on Inven
See how Inven turns hours of manual research into a single, structured workflow.